Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-28T15:20:19.150Z Has data issue: false hasContentIssue false
  • English
  • Français

A training programme involving automatic self-transcending meditation in late-life depression: preliminary analysis of an ongoing randomised controlled trial - RETRACTED

Published online by Cambridge University Press:  02 January 2018

Akshya Vasudev ,
Amanda Arena ,
Amer M. Burhan ,
Emily Ionson ,
Hussein Hirjee ,
Pramudith Maldeniya ,
Stephen Wetmore  and
Ronnie I. Newman
Akshya Vasudev*
Affiliation:
MBBS, MD, MRCPsych, Divisions of Geriatric Psychiatry and Clinical Pharmacology, Departments of Psychiatry and Medicine, Western University, London, Ontario, Canada
Amanda Arena
Affiliation:
PhD, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, London, Ontario, Canada
Amer M. Burhan
Affiliation:
MD, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, London, Ontario, Canada
Emily Ionson
Affiliation:
HBSc, DCTM, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, London, Ontario, Canada
Hussein Hirjee
Affiliation:
MMath, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, London, Ontario, Canada
Pramudith Maldeniya
Affiliation:
MD, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, London, Ontario, Canada
Stephen Wetmore
Affiliation:
MD, Department of Family Medicine, University of Western Ontario, London, Ontario, Canada
Ronnie I. Newman
Affiliation:
EdM, CAS, Art of Living Foundation, Canada; Nova Southeastern University Lifelong Learning Institute, Davie, FL, USA
*
Dr Akshya Vasudev, Division of Geriatric Psychiatry, Department of Psychiatry, Western University, #A2-607, Victoria Hospital, 800 Commissioners Road East, London, Ontario, Canada N6A 5W9. Email: akshya.vasudev@uwo.ca
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Late-life depression affects 2–6% of seniors aged 60 years and above. Patients are increasingly embracing non-pharmacological therapies, many of which have not been scientifically evaluated. This study aimed to evaluate a category of meditation, automatic self-transcending meditation (ASTM), in alleviating symptoms of depression when augmenting treatment as usual (NCT02149810). The preliminary results of an ongoing single-blind randomised controlled trial comparing a training programme involving ASTM with a wait-list control indicate that a 12-week ASTM programme may lead to significantly greater reductions in depression and anxiety severity. As such, ASTM may be an effective adjunctive therapy in the treatment of late-life depression.

Type
Short Report
Information
BJPsych Open , Volume 2 , Issue 2 , March 2016 , pp. 195 - 198
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Copyright
Copyright © The Royal College of Psychiatrists 2016

Footnotes

Declaration of interest

R.I.N. is Director of Research and Health Promotion for the Art of Living Foundation, Canada and supervised the staff providing ASTM training.

References

1 Steffens, DC, Skoog, I, Norton, MC, Hart, AD, Tschanz, JT, Plassman, BL, et al. Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry 2000; 57: 601–7.Google Scholar
2 Canadian Mental Health Association. Alberta: Senior's Suicide Prevention Resource Toolkit. CMHA, 2014 (http://www.suicideinfo.ca).Google Scholar
3 Trivedi, MH, Rush, AJ, Wisniewski, ST, Nierenberg, AA, Warden, D, Ritz, L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28–40.Google Scholar
4 Roth, R. Maharishi Mahesh Yogi's Transcendental Meditation. Primus, 1994.Google Scholar
5 Toane, EB. The transcendental meditation program. Can Med Assoc J 1976; 114: 1095–6.Google Scholar
6 Travis, F, Pearson, C. Pure consciousness: distinct phenomenological and physiological correlates of “consciousness itself”. Int J Neurosci 2000; 100: 77–89.10.3109/00207450008999678Google Scholar
7 Amtul, Z, Arena, A, Hirjee, H, Khan, ZU, Maldeniya, PM, Newman, RI, et al. A randomized controlled longitudinal naturalistic trial testing the effects of automatic self transcending meditation on heart rate variability in late life depression: study protocol. BMC Complement Altern Med 2014; 14: 307.Google Scholar
8 Hamilton, A. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.Google Scholar
9 Yesavage, JA, Brink, TL, Rose, TL, Lum, O, Huang, V, Adey, M, et al. Development and validation of a Geriatric Depression Scale: a preliminary report. J Psychiatr Res 1982; 17: 37–49.Google Scholar
10 Pachana, NA, Byrne, GJ, Siddle, H, Koloski, N, Harley, E, Arnold, E. Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr 2007; 19: 103–14.Google Scholar
11 Trijsburg, RW, Van't Spijker, A, Van Dam, D, Duivenvoorden, HJ. De helping alliance questionnaire (HAQ-II). Tijdschr Psychother 1999; 25: 56–65.10.1007/BF03061895Google Scholar
12 Raphael, D, Brown, I, Renwick, R, Cava, M, Weir, N, Heathcote, K. Measuring the quality of life of older persons: a model with implications for community and public health nursing. Int J Nurs Stud 1997; 34: 231–9.Google Scholar
13 Vanderkooy, JD, Kennedy, SH, Bagby, RM. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of buproprion, moclobemide, paroxetine, setraline, and vanlafaxine. Can J Psychiatry 2002; 47: 174–80.Google Scholar
14 Washburn, RA, Smith, KW, Jette, AM, Janney, CA. The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46: 153–62.Google Scholar
15 Saghaei, M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol 2004; 4: 26.Google Scholar
16 Glueck, BC, Stroebel, CF. Biofeedback and meditation and the treatment of psychiatric illness. Comp Psychiatry 1975; 16: 303–21.Google Scholar
17 Stroebel, CF, Glueck, BC. Passive meditation: subjective, clinical, and electrographic comparison with biofeedback. In Consciousness and Self Regulation, Vol 2 (eds Schwartz, GE, Shapiro, D). Plenum Press, 1978.Google Scholar
18 Glueck, BC, Charles, F. Stroebel. Meditation in the Treatment of Psychiatric Illness. Meditation: Classic and Contemporary Perspectives: p. 150. Alden Publications, 1984.Google Scholar
19 Ottoson, J-O. Swedish National Health Board Report on Transcendental Meditation, (D: nr SN-3-9-1194/73). Socialstyrelsen,1977.Google Scholar
20 Haratani, T, Henmi, T. Effects of transcendental meditation on mental health of industrial workers. Jpn J Public Health 1990; 32: 177.Google Scholar
21 Orme-Johnson, DW, Herron, RE. An innovative approach to reducing medical care utilization and expenditures. Am J Manag Care 1997; 3: 135–44.Google Scholar
22 Schneider, RH, Staggers, F, Alxander, CN, Sheppard, W, Rainforth, M, Kondwani, K, et al. A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension 1995; 26: 820–7.Google Scholar
23 Hollon, SD, Ponniah, K. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety 2010; 27: 891–932.Google Scholar
24 Toneatto, T, Nguyen, L. Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Can J Psychiatry 2007; 52: 260.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.